Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2025

Stockholders’ Equity [Abstract]

Schedule of Restricted Stock Granted Issued and Exercisable

The restricted stock granted, issued and exercisable at March 31, 2025 is as follows:

		Restricted Stock Granted and Vested
Grant date Price		Number Granted		Weighted Average Fair Value per Share
$	1.47		683,167	$	1.47
$	1.50		33,333		1.50
$	1.65		66,667		1.65
			783,167	$	1.50

Schedule of Fair Value of the Warrants Granted and Issued

The fair value of the warrants granted, repriced and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

	Three months ended March 31, 2025
Exercise price	$	0.001105 to 0.084
Risk free interest rate		3.94 to 4.46	%
Expected life		5 months to 5 years
Expected volatility of underlying stock		183.1 to 207.0	%
Expected dividend rate		0	%

	Three months ended March 31, 2025
Exercise price	$	0.09
Risk free interest rate		4.67	%
Expected life		Ten years
Expected volatility of underlying stock		200.7	%
Expected dividend rate		0	%

Schedule of Warrant Activity

A summary of warrant activity during the period January 1, 2024 to March 31, 2025 is as follows:

	Shares Underlying Warrants		Exercise price per share		Weighted average exercise price
Outstanding January 1, 2024		10,442,093	$	0.345 – 5.625	$	0.626500
Granted		1,796,493		0.084 to 0.345		0.267000
Increase in warrants issued due to anti-dilution price protection		9,773,028		0.0840		0.084000
Forfeited		-		-		-
Exercised		-		-		-
Outstanding December 31, 2024		22,011,614	$	0.084 – 5.625	$	0.319900
Granted		2,654,761		0.084		0.084000
Increase in warrants issued due to anti-dilution price protection		969,111,567		0.001105		0.001105
Forfeited		-		-		-
Exercised		-		-		-
Outstanding March 31, 2025		993,777,942	$	0.001105 – 5.625	$	0.007300

Schedule of Warrants Outstanding and Exercisable

The warrants outstanding and exercisable at March 31, 2025 are as follows:

		Warrants Outstanding						Warrants Exercisable
Exercise Price*		Number Outstanding		Weighted Average Remaining Contractual life in years		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price		Weighted Average Remaining Contractual life in years
$	0.001105		982,487,834		2.69				982,487,834				2.69
	0.084000		2,654,761		4.83				2,654,761				4.83
$	0.345000		7,248,896		3.44				7,248,896				3.44
$	0.450000		266,668		3.23				266,668				3.23
$	1.035000		500,000		0.27				500,000				0.27
$	1.500000		33,334		3.37				33,334				3.37
$	4.500000		505,560		0.96				505,560				0.96
$	5.625000		80,889		0.96				80,889				0.96
			993,777,942		2.70	$	0.007300		993,777,942	$	0.007300		2.70

Schedule of Option Activity

A summary of option activity during the period January 1, 2024 to March 31, 2025 is as follows:

	Shares Underlying options			Exercise price per share		Weighted average exercise price
Outstanding January 1, 2024		1,520,002		$	1.20 to 12.00	$	4.46
Granted		-			-		-
Forfeited/Cancelled		(6,667	)		1.20		1.20
Exercised		-			-		-
Outstanding December 31, 2024		1,513,335		$	1.20 to 12.00	$	4.47
Granted		600,000			0.09		0.09
Forfeited/Cancelled		-			-		-
Exercised		-			-		-
Outstanding March 31, 2025		2,113,335		$	0.09 to 12.00	$	3.227

Schedule of Options Outstanding and Exercisable

The options outstanding and exercisable at March 31, 2025 are as follows:

		Options Outstanding						Options Exercisable
Exercise Price*		Number Outstanding		Weighted Average Remaining Contractual life in years		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price		Weighted Average Remaining Contractual life in years
$	0.09		600,000		9.78				325,000				9.78
$	1.20		13,334		7.46				13,334				7.46
$	4.50		1,500,001		6.69				1,500,001				6.69
			2,113,335		7.57	$	3.227		1,838,335	$	3.696		7.24